Kinase Drug Discovery by Affinity Selection/Mass Spectrometry (ASMS): Application to DNA Damage Checkpoint Kinase Chk1
Open Access
- 1 October 2006
- journal article
- research article
- Published by Elsevier BV in SLAS Discovery
- Vol. 11 (7), 755-764
- https://doi.org/10.1177/1087057106289972
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Chk1 and Chk2 kinases in checkpoint control and cancerCancer Cell, 2003
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Novel chemical genetic approaches to the discovery of signal transduction inhibitorsDrug Discovery Today, 2002
- Protein kinases — the major drug targets of the twenty-first century?Nature Reviews Drug Discovery, 2002
- Inhibition of p38 MAP kinase by utilizing a novel allosteric binding siteNature Structural & Molecular Biology, 2002
- Protein kinase inhibitors: emerging pharmacophores 1997 - 2000Expert Opinion on Therapeutic Patents, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine KinaseScience, 2000
- Implications for Chk1 Regulation: The 1.7 Å Crystal Structure of Human Cell Cycle Checkpoint Kinase Chk1Cell, 2000
- Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signalingCell, 1995